Lifeboat Foundation

Washington (AFP) — Amazon, Microsoft and Intel are among leading tech companies putting the world at risk through killer robot development, according to a report that surveyed major players from the sector about their stance on lethal autonomous weapons.

Dutch NGO Pax ranked 50 companies by three criteria: whether they were developing technology that could be relevant to deadly AI, whether they were working on related military projects, and if they had committed to abstaining from contributing in the future.

“Why are companies like Microsoft and Amazon not denying that they’re currently developing these highly controversial weapons, which could decide to kill people without direct human involvement?” said Frank Slijper, lead author of the report published this week.

Together with the University of Innsbruck, the ETH Zurich and Interactive Fully Electrical Vehicles SRL, Infineon Austria is researching specific questions on the commercial use of quantum computers. With new innovations in design and manufacturing, the partners from universities and industry want to develop affordable components for quantum computers.

Hologram messaging is a sci-fi staple that has captured people’s collective imaginations for years.

The new finding could lead to technology straight out of sci-fi.

Continue reading “New Research Could Lead to Smartwatches with Holographic Displays” »

Judges are far from being infallible. For example, in psychologist Daniel Kahneman’s book Thinking Fast and Slow, it was shown that there is a correlation between the leniency of a judge in court, and how recently they had eaten lunch.

Is there a way to get around this problem? According to China and Estonia, AI should be the judge — literally.

RELATED: A NEW AI TOOL CAN HELP US FIGHT AI-WRITTEN FAKE NEWS AND REVIEWS

⏪🕰 2009 – Using a new modeling program, Lab researchers predict the collision between the defunct Russian Cosmos 2251 and privately-owned American Iridium 33 satellite months before it happened.

Learn more 🛰→ https://str.llnl.gov/content/pages/past-issues-pdfs/2009.07.pdf

BOSTON — Sea Machines Robotics Inc. this week said it has entered into a cooperative agreement with the U.S. Department of Transportation’s Maritime Administration to demonstrate the ability of its autonomous technology in increasing the safety, response time and productivity of marine oil-spill response operations.

Sea Machines was founded in 2015 and claimed to be “the leader in pioneering autonomous control and advanced perception systems for the marine industries.” The company builds software and systems to increase the safety, efficiency, and performance of ships, workboats, and commercial vessels worldwide.

Continue reading “Sea Machines Robotics to demonstrate autonomous spill response” »

Fronteirs offers open access. If you want to read full publications this is the place to do so. #enjoy

Download this month’s new releases including the latest research collections on Tinnitus, Brain Aging, Arboviral Infections, and many more! All eBooks are free to download, share and distribute.

Shape the future of your field — and publish your own eBook — by editing an article collection around your research area. Learn more about Research Topics or submit your suggestion to [email protected]

Continue reading “Frontiers eBooks published in July 2019” »

The particle tracks emanating from a high energy collision at the LHC in 2014 show the creation of many new particles. It’s only because of the high-energy nature of this collision that new masses can be created.

Researchers at Georgetown Lombardi Comprehensive Cancer Center have decoded a chain of molecules that are critical for the growth and survival of pancreatic ductal adenocarcinoma (PDAC)—the most common and also the most lethal form of pancreatic cancer.

They say their findings, published in Developmental Cell, suggest that inhibiting this “Yap” biological network may effectively regress early stage PDAC and could be paired with other drugs to halt more advanced stage tumors. Yap inhibitors have been developed and are moving into clinical trials.

Their study builds upon Georgetown Lombardi research that previously identified Yap as an oncogene central to the initiation of PDAC as well as a variety of other cancers. In the current study employing advanced animal models, they have managed to switch off Yap in pre-established PDAC tumors, and discovered that suppressing Yap blocks the metabolic pathways that provide the fuel and building materials for maintaining the growth of the cancer.